VSTM FY 2018 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$376M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M

Gross Profit

$26M97.8% margin

Operating Income

-$95M-354.8% margin

Net Income

-$72M-271.1% margin

EPS (Diluted)

$-12.54

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$98M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$277M

Total Liabilities

$153M

Stockholders' Equity

$124M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$0	—
Gross Profit	$26M	-$556,000	+4799.6%
Operating Income	-$95M	-$68M	-39.8%
Net Income	-$72M	-$68M	-6.8%